Household Transmission of SARS-CoV-2, Zhuhai, China, 2020.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
19 11 2020
Historique:
received: 10 04 2020
accepted: 07 05 2020
pubmed: 12 5 2020
medline: 15 12 2020
entrez: 12 5 2020
Statut: ppublish

Résumé

To illustrate the extent of transmission, identify affecting risk factors and estimate epidemiological modeling parameters of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in household setting. We enrolled 35 confirmed index cases and their 148 household contacts, January 2020-February 2020, in Zhuhai, China. All participants were interviewed and asked to complete questionnaires. Household contacts were then prospectively followed active symptom monitoring through the 21-day period and nasopharyngeal and/or oropharyngeal swabs were collected at 3-7 days intervals. Epidemiological, demographic, and clinical data (when available) were collected. Assuming that all these secondary cases were infected by their index cases, the second infection rate in household context is 32.4% (95% confidence interval [CI]: 22.4%-44.4%), with 10.4% of secondary cases being asymptomatic. Multivariate analysis showed that household contacts with underlying medical conditions, a history of direct exposure to Wuhan and its surrounding areas, and shared vehicle with an index patient were associated with higher susceptibility. Household members without protective measures after illness onset of the index patient seem to increase the risk for SARS-CoV-2 infection. The median incubation period and serial interval within household were estimated to be 4.3 days (95% CI: 3.4-5.3 days) and 5.1 days (95% CI: 4.3-6.2 days), respectively. Early isolation of patients with coronavirus disease 2019 and prioritizing rapid contact investigation, followed by active symptom monitoring and periodic laboratory evaluation, should be initiated immediately after confirming patients to address the underlying determinants driving the continuing pandemic.

Sections du résumé

BACKGROUND
To illustrate the extent of transmission, identify affecting risk factors and estimate epidemiological modeling parameters of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in household setting.
METHODS
We enrolled 35 confirmed index cases and their 148 household contacts, January 2020-February 2020, in Zhuhai, China. All participants were interviewed and asked to complete questionnaires. Household contacts were then prospectively followed active symptom monitoring through the 21-day period and nasopharyngeal and/or oropharyngeal swabs were collected at 3-7 days intervals. Epidemiological, demographic, and clinical data (when available) were collected.
RESULTS
Assuming that all these secondary cases were infected by their index cases, the second infection rate in household context is 32.4% (95% confidence interval [CI]: 22.4%-44.4%), with 10.4% of secondary cases being asymptomatic. Multivariate analysis showed that household contacts with underlying medical conditions, a history of direct exposure to Wuhan and its surrounding areas, and shared vehicle with an index patient were associated with higher susceptibility. Household members without protective measures after illness onset of the index patient seem to increase the risk for SARS-CoV-2 infection. The median incubation period and serial interval within household were estimated to be 4.3 days (95% CI: 3.4-5.3 days) and 5.1 days (95% CI: 4.3-6.2 days), respectively.
CONCLUSION
Early isolation of patients with coronavirus disease 2019 and prioritizing rapid contact investigation, followed by active symptom monitoring and periodic laboratory evaluation, should be initiated immediately after confirming patients to address the underlying determinants driving the continuing pandemic.

Identifiants

pubmed: 32392331
pii: 5835845
doi: 10.1093/cid/ciaa557
pmc: PMC7239243
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2099-2108

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Jian Wu (J)

Department of Pulmonary and Critical Care Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Guangdong Provincial Key Laboratory of Biomedical Imaging, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Yiying Huang (Y)

Department of Pulmonary and Critical Care Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Changli Tu (C)

Department of Pulmonary and Critical Care Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Chunping Bi (C)

Department of Pulmonary and Critical Care Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Zhigang Chen (Z)

Department of Neurology, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Liyun Luo (L)

Department of Cardiovascular Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Mingxing Huang (M)

Department of Infectious Diseases, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Meizhu Chen (M)

Department of Pulmonary and Critical Care Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Cuiyan Tan (C)

Department of Pulmonary and Critical Care Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Zhenguo Wang (Z)

Department of Pulmonary and Critical Care Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Kongqiu Wang (K)

Department of Pulmonary and Critical Care Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

YingJian Liang (Y)

Department of Pulmonary and Critical Care Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Jin Huang (J)

Department of Pulmonary and Critical Care Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Xiaobin Zheng (X)

Department of Pulmonary and Critical Care Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Jing Liu (J)

Department of Pulmonary and Critical Care Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Guangdong Provincial Key Laboratory of Biomedical Imaging, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH